Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Diamond, Jennifer R., Becerra, Carlos, Richards, Donald, Mita, Alain, Osborne, Cynthia, OâShaughnessy, Joyce, Zhang, Chun, Henner, Randall, Kapoun, Ann M., Xu, Lu, Stagg, Bob, Uttamsingh, Shailaja,Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-020-05817-w
Date:
August, 2020
File:
PDF, 923 KB
2020
File converter
More search results
More benefits 
